Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2006; 12(6): 945-950
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.945
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.945
Table 5 Incidence of selected laboratory abnormalities (>10% frequency)
| Laboratory abnormality | Regimen A(CIFN+zinc) | Regimen B(CIFN) |
| n | 41 | 42 |
| Thrombocytopenia | 31 (78%) | 29 (69%) |
| Leucopenia | 24 (59%) | 30(71%) |
| Increase in AST | 20 (49%) | 18 (43%) |
| Increase in ALT | 18 (44%) | 16 (38%) |
| Increase in γ-GTP | 12 (29%) | 12 (29%) |
| Decrease in hemoglobin | 7 (17%) | 9 (21%) |
| Increase in ZTT | 7 (17%) | 7 (17%) |
- Citation: Suzuki H, Sato K, Takagi H, Kanda D, Sohara N, Kakizaki S, Nakajima H, Otsuka T, Nagamine T, Mori M. Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2. World J Gastroenterol 2006; 12(6): 945-950
- URL: https://www.wjgnet.com/1007-9327/full/v12/i6/945.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i6.945